
Shares of Tylenol maker Kenvue KVUE.N fall 4% to $17.61
U.S. President Donald Trump said on Saturday his administration would make announcement about its autism findings on Monday, declining to offer specifics
The Wall Street Journal reported earlier this month that Health Secretary Robert F. Kennedy Jr. plans to announce that use of KVUE's popular over-the-counter pain medication, Tylenol, by pregnant women is potentially linked to autism, contrary to medical guidelines that say it is safe to use
Kenvue has previously said it continues to believe that taking acetaminophen - the active ingredient in Tylenol - does not cause autism
Up to last close, stock down 14.1% YTD